Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Echolalia, Pica, Smooth philtrum, and Intellectual disability and others; and very common findings: Motor delay, Stereotypical hand wringing, Delayed speech and language development, and Limb dystonia. 76 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 21 | Mild intellectual disability, Moderate intellectual disability, Seizure |
Digestive system | 5 | Abdominal distention, Constipation, Inflammation of the large intestine |
Arms and legs | 5 | Recurrent hand flapping, Clinodactyly of the 5th finger, Stereotypic upper-extremity movements |
Muscles | 3 | Low muscle tone (hypotonia), Writer's cramp, Cerebellar vermis atrophy |
Head and neck | 2 | Macrocephaly, Mandibular prognathia |
Growth and development | 1 | Tall stature |
Lab test results | 1 | Hyperbilirubinemia |
Bones and joints | 1 | Excessive outward curvature of the upper spine (kyphosis) |
Eyes | 1 | Ptosis |
Hormones | 1 | Hypothyroidism |
To date, 115 individuals have been identified with a pathogenic heterozygous sequence variant in CHD8 for whom some phenotypic information is reported [, , , , , , , , , , , , , , , , , , , , , , , ]. Of the 103 individuals for whom sex is known, 69 (67%) are male. This suggests a 2:1 male-to-female ratio, which is lower than the sex disparity previously reported . The reason for this sex difference is unknown, but it mirrors that of other neurodevelopmental disorders, indicating a possible ascertainment bias in who is referred for genetic testing. The following description of the phenotypic features associated with CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD) is based on these reports. Table 2. Select Features of CHD8-Related Neurodevelopmental Disorder with Overgrowth
Feature | % of Persons w/Feature | Comment |
|---|---|---|
Macrocephaly | 80% | — |
Tall stature | 80% | — |
ASD | 75%-80% | — |
DD/ID | 75%-80% | Most, if not all, affected persons have some degree of DD.; Speech motor delays are common.; ID is usually mild to moderate.; Possible developmental regression is observed in up to half of affected persons. |
Sleep disturbances | 67% | — |
Gastrointestinal problems | 63% | Most frequently constipation |
ADHD | 50% | — |
Anxiety | 29% | — |
Hypotonia | 27% | — |
Seizures | 12% | ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder; DD = developmental delay; ID = intellectual disorder; Developmental delay (DD) in early childhood is common in individuals with CHD8-NDD. |
Source: GeneReviews — "CHD8-Related Neurodevelopmental Disorder with Overgrowth"
CHD8 encodes chromodomain helicase DNA binding protein 8 (2,581 aa). ATP-dependent chromatin-remodeling factor, it slides nucleosomes along DNA; nucleosome sliding requires ATP. Highest expression in Brain Cerebellar Hemisphere (39.4 TPM) and Brain Cerebellum (37.7 TPM).
Intellectual developmental disorder with autism and macrocephaly is associated with mutations in the CHD8 gene on chromosome 14.
The CHD8 protein participates in CHD7 and CHD8 bind FAM124B, CHD8 and CHD7 bind CTCF, and CHD8:CTNNB1 represses AXIN2 expression pathways.
CHD8 is classified as a druggable target (Enzyme category) with score 0.0.
No consensus clinical diagnostic criteria for CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD) have been published.
CHD8-NDD should be considered in individuals with the following clinical and family history findings.
Clinical findings
Developmental delay (DD) and/or intellectual disability (ID) (typically in the mild-to-moderate range)
Neuropsychiatric disorders, including autism spectrum disorder (ASD)
Generalized overgrowth, including tall stature and macrocephaly
Sleep disturbance
Gastrointestinal problems, especially constipation
Source: GeneReviews — "CHD8-Related Neurodevelopmental Disorder with Overgrowth"
Overgrowth conditions of interest in the differential diagnosis of CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD) are summarized in . Table 3. Overgrowth Conditions to Consider in the Differential Diagnosis of CHD8-Related Neurodevelopmental Disorder with Overgrowth
Gene(s)/GeneticMechanism | Differential Disorder | MOI | Clinical Features of Differential Disorder |
|---|---|---|---|
Beckwith-Wiedemann syndrome | Varies by genetic mechanism | Macrosomia | Neonatal hypoglycemia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors, visceromegaly, adrenocortical cytomegaly, renal abnormalities, ear creases/pits DNMT3A |
Genetic testing for CHD8 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual developmental disorder with autism and macrocephaly has been reported in the published literature.
No approved treatments are currently available for intellectual developmental disorder with autism and macrocephaly. The disease remains an area of unmet medical need.
No clinical practice guidelines for CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD) have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with CHD8-NDD, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with CHD8-Related Neurodevelopmental Disorder with Overgrowth
System/Concern | Evaluation | Comment |
|---|---|---|
Constitutional | Measurement of all growth parameters incl head circumference | To assess for signs of macrocephaly generalized overgrowth |
Development | Developmental assessment | To incl eval of cognitive, speech-language, adaptive, social/emotional, motor skills; Eval for early intervention/ special education; Consider referral to developmental pediatrician, psychologist, /or speech-language pathologist as warranted. Neurobehavioral/ |
Psychiatric | Behavioral history exam | Incl screening for concerns such as sleep disturbances, ADHD, anxiety, findings suggestive of ASD; Consider referral to psychologist /or psychiatrist as warranted. |
Neurologic | Neurologic history exam1 | To incl brain MRI if HC ≥3 SDs above mean, person has rapidly HC, or signs/symptoms of CSF obstruction2 or compression of brain stem, cerebellum, or cranial nerves.3 Consider brain MRI if HC 2 SDs above mean, in absence of other symptoms. |
Source: GeneReviews — "CHD8-Related Neurodevelopmental Disorder with Overgrowth"
View trials for intellectual developmental disorder with autism and macrocephaly
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the following evaluations are recommended.
Table 6.
Recommended Surveillance for Individuals with CHD8-Related Neurodevelopmental Disorder with Overgrowth
System/Concern | Evaluation | Frequency
| Measurement of growth parameters incl head circumference | At each visit1
| Monitor developmental progress educational needs.
Psychiatric/
| Monitor for signs/symptoms of anxiety, psychosis, ASD, ADHD, aggressive or self-injurious behavior.
| Monitor those w/seizures as clinically indicated.
Assess for new manifestations such as seizures; changes in tone/movement disorders; signs/symptoms of CSF obstruction,2 compression of brain stem, cerebellum, or cranial nerves,3 or spinal cord dysfunction.4
Consider serial imaging for asymptomatic or minimally symptomatic Chiari I malformation detected previously.5 | As clinically indicated
| Screening for signs/symptoms of sleep disturbance | At each visit
| Monitor for signs/symptoms of constipation feeding issues.
Family/
| Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) care coordination.
ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder
1. Head circumference should be measured until adulthood.
2. For example, valsalva-induced occipital headache or cervical pain
Source: GeneReviews — "CHD8-Related Neurodevelopmental Disorder with Overgrowth"
Phenotype severity distribution: 21 always present features, 4 very common features, 24 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intellectual developmental disorder with autism and macrocephaly.
69 publications have been identified in PubMed for intellectual developmental disorder with autism and macrocephaly. Research spans Basic Science / Preclinical (32%), Epidemiology / Natural History (26%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 22 | 32% |
Disease patterns and progression | 18 | 26% |
Research summaries | 9 | 13% |
Testing and diagnosis research | 8 | 12% |
Patient case studies | 5 | 7% |
Clinical study results | 5 | 7% |
Other research | 2 | 3% |
Lan SC (2026). [PMID: 41309157](https://pubmed.ncbi.nlm.nih.gov/41309157/). *Clinical genetics*. [Case Report / Case Series]
Osterne VJS (2026). [PMID: 41590571](https://pubmed.ncbi.nlm.nih.gov/41590571/). *Membranes*. [Review / Meta-Analysis]
Wu Y (2026). [PMID: 41752141](https://pubmed.ncbi.nlm.nih.gov/41752141/). *International journal of molecular sciences*. [Epidemiology / Natural History]
Alemany S (2026). [PMID: 40543799](https://pubmed.ncbi.nlm.nih.gov/40543799/). *J Am Acad Child Adolesc Psychiatry*. [Epidemiology / Natural History]
Zhang J (2026). [PMID: 41693594](https://pubmed.ncbi.nlm.nih.gov/41693594/). *Autism research : official journal of the International Society for Autism Research*. [Basic Science / Preclinical]
Ralph P (2026). [PMID: 41625139](https://pubmed.ncbi.nlm.nih.gov/41625139/). *SAGE open medical case reports*. [Case Report / Case Series]
Xie F (2026). [PMID: 41606982](https://pubmed.ncbi.nlm.nih.gov/41606982/). *Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]*. [Basic Science / Preclinical]
Tiosso Batistetti V (2026). [PMID: 41955613](https://pubmed.ncbi.nlm.nih.gov/41955613/). *JMIR Infodemiology*. [Epidemiology / Natural History]
Wang H (2026). [PMID: 42201483](https://pubmed.ncbi.nlm.nih.gov/42201483/). *Mol Neurobiol*. [Basic Science / Preclinical]
Chen Z (2026). [PMID: 42105015](https://pubmed.ncbi.nlm.nih.gov/42105015/). *J Autism Dev Disord*. [Other]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 2:40 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Tatton-Brown-Rahman syndrome
AD |
Overgrowth, DD/ID, ASD, behavior problems, hypotonia |
Kyphoscoliosis, cryptorchidism, hematologic malignancies, obesity |
EED | EED-related overgrowth (Cohen-Gibson syndrome) | AD | Overgrowth (tall stature, macrocephaly), mild-to-severe ID |
EZH2 | EZH2-related Weaver syndrome (See EZH2-Related Overgrowth.) | AD | Tall stature, normal intellect to severe ID |
FMR1 | Fragile X syndrome (See FMR1 Disorders.) | XL | DD/ID, ASD, anxiety behavior problems, hypotonia, seizures, GI problems, sleep disorders |
Simpson-Golabi-Behmel syndrome type 1 | XL | Pre- postnatal macrosomia, mild-to-severe ID | Distinctive craniofacial features, congenital anomalies, skeletal problems NFIX |
NFIX-related Malan syndrome | AD | Overgrowth, macrocephaly, DD, learning disability, ASD, hypotonia | Distinctive facial appearance, pectus excavatum, coxa valga, livedo reticularis, abnormalities on brain MRI NSD1 |
Sotos syndrome | AD | Learning disability, mild-to-severe ID, ASD, overgrowth, seizures | Distinctive facial appearance, advanced bone age, cardiac anomalies, joint hyperlaxity, renal anomalies, scoliosis PTCH1 SUFU |
Nevoid basal cell carcinoma syndrome | AD | Macrocephaly, gross motor delays | Jaw keratocytes, basal cell carcinomas, frontal bossing, coarse facial features, facial milia, skeletal anomalies, ectopic calcification of falx, cardiac ovarian fibromas PTEN |
PTEN hamartoma tumor syndrome | AD | Macrocephaly, DD, ASD | Benign malignant tumors of thyroid, breast, kidney, endometrium, trichilemmomas, papillomatous papules |
SUZ12 | Imagawa-Matsumoto syndrome (OMIM 618786) | AD | Overgrowth, macrocephaly, hypotonia, DD, mild-to-severe ID ... |
Source: GeneReviews — "CHD8-Related Neurodevelopmental Disorder with Overgrowth"
Feeding | GI- feeding-directed history exam | To incl eval for constipation other GI problems; Consider referral to gastroenterologist, as warranted. Genetic |
counseling | By genetics professionals4 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of CHD8-NDD to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with CHD8-Related Neurodevelopmental Disorder with Overgrowth Manifestation/Concern | Treatment | Considerations/Other Developmental delay/ Intellectual disability/ |
Behavioral issues | See . | — |
Epilepsy | Standardized treatment w/ASM by experienced neurologist | Many ASMs may be effective; none has been demonstrated effective specifically for CHD8-NDD.; Education of parents/caregivers1 |
Dystonia | Standard treatment per neurologist | 2 affected persons w/childhood-onset progressive dystonia that was unresponsive to pharmacologic therapy experienced improvement w/deep brain stimulation.2 Chiari I malformation |